EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access · CC BY 4.0

Medication burden among adults with cystic fibrosis prescribed CFTR Modulators: a cross-sectional survey

Nicola Shaw, Daniel G Peckham, Ian Kellar, Nikki Rousseau, Stephen J Bourke, Alan Anderson, Muhammed Faisal, David P Alldred

Journal of Cystic Fibrosis · 2026-11

DOI: 10.1016/j.jcf.2026.10.007 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift Journal of Cystic Fibrosis, 2026-11. Verfasst von Nicola Shaw und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Healthcare, Faculty of Medicine, University of Leeds, UK; Adult Cystic Fibrosis Unit, Leeds Teaching Hospitals NHS Trust, UK. Electronic ad…. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute for Health and Care Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: While CFTR modulators (CFTRm) have transformed clinical outcomes in CF, their impact on perceived medicines-related burden is not fully understood. This study aimed to quantify medicines-related burden in adults with CF prescribed CFTRm. METHODS: A cross-sectional survey was conducted between September and December 2022 in two adult CF centres in the North of England. Subjects >16 years and receiving CFTR modulator therapy were recruited in both inpatient and outpatient settings. Medicines-related burden was assessed using the validated Living with Medicines Questionnaire version 3 (LMQ-3). Data on use of pancreatic enzyme replacement therapy (PERT), insulin, number of daily medicines, and self-reported lung function (ppFEV₁%) was also captured. RESULTS: Of 577 eligible participants, 346 completed the survey (60%). The mean (SD) age was 33.6 (±12) years, with 190 (54.9%) male. The mean LMQ-3 score was 83.01 (SD 18.8; range 42-127). Minimal, moderate and high burden was experienced in 58.4%, 32.9% and 8.7% of subjects respectively. Higher burden was significantly associated with receiving help in managing medicines, greater number of daily medicines, lower educational attainment, and unemployment. No significant associations were observed for age, sex, lung function, pancreatic or diabetic status. CONCLUSION: Despite the introduction of CFTRm therapy, medicines-related burden remains prevalent. Greater burden is associated with polypharmacy, need for support, and socioeconomic factors. The LMQ-3 may be a useful screening tool to identify individuals requiring targeted interventions to reduce treatment burden.

Schlagwörter

Stichwörter der Autor:innen

AdherenceCFTR modulatorCFTR modulator therapyCystic fibrosisLiving with medicines questionnaire (LMQ-3)Medicine adherenceMedicine-related burdenPatient reported outcomesPolypharmacySelf-managementTreatment burden

Autor:innen und Institutionen

  • School of Healthcare, Faculty of Medicine, University of Leeds, UK; Adult Cystic Fibrosis Unit, Leeds Teaching Hospitals NHS Trust, UK. Electronic address: nicola.shaw20@nhs.net.
  • Adult Cystic Fibrosis Unit, Leeds Teaching Hospitals NHS Trust, UK; Leeds Institute of Medical Research, University of Leeds, UK.
  • School of Psychology, University of Sheffield, UK.
  • Leeds Institute of clinical Trial Research, University of Leeds, UK.
  • Newcastle upon Tyne Hospitals NHS Foundation Trust, UK.
  • Centre for Digital Innovations in Health and Social Care, Institute of Health and Social Care, University of Bradford, UK; Wolfson Centre for Applied Health Research, Bradford Royal Infirmary, UK.

Förderung

  • National Institute for Health and Care Research

Zitieren

APA

Shaw, N., Peckham, D. G., Kellar, I., Rousseau, N., Bourke, S. J., Anderson, A., Faisal, M., & Alldred, D. P. (2026). Medication burden among adults with cystic fibrosis prescribed CFTR Modulators: a cross-sectional survey. Journal of Cystic Fibrosis. https://doi.org/10.1016/j.jcf.2026.10.007

Vancouver

Shaw N, Peckham DG, Kellar I, Rousseau N, Bourke SJ, Anderson A, et al. Medication burden among adults with cystic fibrosis prescribed CFTR Modulators: a cross-sectional survey. Journal of Cystic Fibrosis. 2026. doi:10.1016/j.jcf.2026.10.007

BibTeX
@article{Shaw2026,
  author = {Shaw, Nicola and Peckham, Daniel G and Kellar, Ian and Rousseau, Nikki and Bourke, Stephen J and Anderson, Alan and Faisal, Muhammed and Alldred, David P},
  title = {Medication burden among adults with cystic fibrosis prescribed CFTR Modulators: a cross-sectional survey},
  journal = {Journal of Cystic Fibrosis},
  year = {2026},
  doi = {10.1016/j.jcf.2026.10.007}
}
Kostenlos starten →